Online inquiry

IVTScrip™ mRNA-Human ABHD14B, (Cap 1, 2-Thio-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK13564MR)

This product GTTS-WK13564MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 2-Thio-UTP. It ecodes the ABHD14B protein. This product can be used in Liver bud hepatic cell-related researches.
Specifications
Product type mRNA
Modified bases 2-Thio-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001146314.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 84836
UniProt ID Q96IU4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABHD14B, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) (GTTS-WK13564MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK7814MR IVTScrip™ mRNA-Human AAK1, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AAK1
GTTS-WK9822MR IVTScrip™ mRNA-Human ADCY7, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADCY7
GTTS-WK15992MR IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Aldehyde Dehydrogenase 1-A1
GTTS-WK23327MR IVTScrip™ mRNA-Human ASRGL1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASRGL1
GTTS-WK12436MR IVTScrip™ mRNA-Human ACOT9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACOT9
GTTS-WK11243MR IVTScrip™ mRNA-Human ACSBG1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACSBG1
GTTS-WK25436MR IVTScrip™ mRNA-Human ATAD2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ATAD2
GTTS-WK13083MR IVTScrip™ mRNA-Human ACYP2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACYP2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →